Mobility Limitation: Clinical Trials

9 trials for Mobility Limitation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 1 terminated, 1 unknown. 9 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 4, Recruiting 3, Terminated 1, Unknown 1
Phase 23Completed 1, Recruiting 1, Terminated 1

Follow Mobility Limitation: new trials by email Literature Review of Mobility Limitation trials Research Report on Mobility Limitation

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Mobility After Revascularization in Peripheral Artery Disease
Home Based Exercise, Nitrate Rich Beetroot Juice, Attention Control - Peripheral Artery Disease, Intermittent Claudication
Phase 3RecruitingNorthwestern University3862025-08-042026-10-05
Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance
Functional Activity Strength Training - Mobility Limitation
Phase 2 / Phase 3RecruitingMilton S. Hershey Medical Center3602025-04-092026-07-22
SMART Exercise for PAD
Supervised Treadmill Exercise, Home-Based Exercise, Nitrate-rich beetroot Juice - Peripheral Arterial Disease, Aging
Phase 3RecruitingNorthwestern University2102023-09-082026-04-15
Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease
Adrabetadex - Niemann-Pick Disease, Type C
Phase 2 / Phase 3TerminatedMandos LLC662015-12-232023-08-29
VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease
Parts A/B: Adrabetadex, Parts A/B: Sham Control - Niemann-Pick Disease, Type C
Phase 2 / Phase 3CompletedMandos LLC562015-10-012023-02-22
Use of Whole-Body Periodic Acceleration Therapy To Aches and Pains
Whole body periodic acceleration (Exer-Rest) - Pain, Stiffness
Phase 3UnknownCenter for Translational Medicine302011-08-012012-06-28
Optimizing Protein Intake in Older Americans With Mobility Limitations
Testosterone enanthate - Mobility Limitation
Phase 3CompletedBrigham and Women's Hospital922011-05-012021-07-29
Laser Light Visual Cueing for Freezing of Gait in Parkinson's Disease
Laser light (U-Step Walking Stabilizer with laser light) - Parkinson Disease
Phase 3CompletedParkinson's Disease Research, Education, and Clinical Center, Philadelphia222003-06-012012-01-02
A Comparison of Weighted Vest Exercise and Strength Training
InVEST (Increased Velocity Exercise Specific to Task) - Mobility Limitations, Aging
Phase 3CompletedNational Institute on Aging (NIA)1602001-07-012010-07-26

Narrower conditions

Cognitive Dysfunction (2)  ·  Deglutition Disorders (2)  ·  Disease (2)  ·  Niemann-Pick Disease, Type C (2)  ·  Peripheral Arterial Disease (2)  ·  Peripheral Vascular Diseases (2)  ·  Behavior (1)  ·  Intermittent Claudication (1)  ·  Pain (1)  ·  Parkinson Disease (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (9)  ·  Signs and Symptoms (9)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Nervous System Diseases (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Atherosclerosis (2)  ·  Brain Diseases, Metabolic (2)  ·  Brain Diseases, Metabolic, Inborn (2)  ·  Cardiovascular Diseases (2)  ·  Cognition Disorders (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Digestive System Diseases (2)  ·  Esophageal Diseases (2)

Interventions

2-Hydroxypropyl-beta-cyclodextrin (2)  ·  Cyclodextrins (2)  ·  Lasers (1)  ·  Nitrates (1)  ·  testosterone enanthate (1)

Sponsors

Mandos LLC (2)  ·  Northwestern University (2)  ·  Brigham and Women's Hospital (1)  ·  Center for Translational Medicine (1)  ·  Milton S. Hershey Medical Center (1)  ·  National Institute on Aging (NIA) (1)  ·  Parkinson's Disease Research, Education, and Clinical Center, Philadelphia (1)

Countries

United States (9)  ·  Australia (2)  ·  France (2)  ·  Germany (2)  ·  New Zealand (2)  ·  Singapore (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Jonathan F. Bean, MD, MS (1)  ·  Lisette Bunting-Perry, PhD, RN (1)  ·  Maggie Nellissery, Ph.D. (1)  ·  Shalender Bhasin, MD (1)

Results publications

PMID 19414509, PMID 19854420, PMID 21143443, PMID 21636073, PMID 22289248, PMID 29188864, PMID 29532075, PMID 30932132, PMID 33417663, PMID 40525490, PMID 42035974

NIH funding

2015 (2), K23AG019663 (1), R01AG037547 (1), R01AG079938 (1)